Return On Equity of Hepion Pharmaceuticals, Inc. from 30 Jun 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Hepion Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2014 to 30 Sep 2025.
  • Hepion Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -401%, a 17% increase year-over-year.
  • Hepion Pharmaceuticals, Inc. annual Return On Equity for 2024 was -548%, a 144% decline from 2023.
  • Hepion Pharmaceuticals, Inc. annual Return On Equity for 2023 was -225%, a 251% decline from 2022.
  • Hepion Pharmaceuticals, Inc. annual Return On Equity for 2022 was -64%, a 108% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Hepion Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -401% +83% +17% 01 Jul 2025 30 Sep 2025
Q2 2025 -870% -541% -165% 01 Apr 2025 30 Jun 2025
Q1 2025 -1096% -827% -308% 01 Jan 2025 31 Mar 2025
Q4 2024 -548% -323% -144% 01 Oct 2024 31 Dec 2024
Q3 2024 -484% -346% -251% 01 Jul 2024 30 Sep 2024
Q2 2024 -329% -230% -232% 01 Apr 2024 30 Jun 2024
Q1 2024 -269% -178% -196% 01 Jan 2024 31 Mar 2024
Q4 2023 -225% -161% -251% 01 Oct 2023 31 Dec 2023
Q3 2023 -138% -79% -134% 01 Jul 2023 30 Sep 2023
Q2 2023 -99% -46% -89% 01 Apr 2023 30 Jun 2023
Q1 2023 -91% -57% -166% 01 Jan 2023 31 Mar 2023
Q4 2022 -64% -33% -108% 01 Oct 2022 31 Dec 2022
Q3 2022 -59% -29% -96% 01 Jul 2022 30 Sep 2022
Q2 2022 -52% -17% -48% 01 Apr 2022 30 Jun 2022
Q1 2022 -34% +13% +27% 01 Jan 2022 31 Mar 2022
Q4 2021 -31% +60% +66% 01 Oct 2021 31 Dec 2021
Q3 2021 -30% +79% +72% 01 Jul 2021 30 Sep 2021
Q2 2021 -35% +43% +55% 01 Apr 2021 30 Jun 2021
Q1 2021 -47% +8% +14% 01 Jan 2021 31 Mar 2021
Q4 2020 -91% -35% -61% 01 Oct 2020 31 Dec 2020
Q3 2020 -109% -27% -33% 01 Jul 2020 30 Sep 2020
Q2 2020 -78% +15% +16% 01 Apr 2020 30 Jun 2020
Q1 2020 -55% +526% +91% 01 Jan 2020 31 Mar 2020
Q4 2019 -57% +379% +87% 01 Oct 2019 31 Dec 2019
Q3 2019 -82% 01 Jul 2019 30 Sep 2019
Q2 2019 -93% 01 Apr 2019 30 Jun 2019
Q1 2019 -581% 01 Jan 2019 31 Mar 2019
Q4 2018 -436% 01 Oct 2018 31 Dec 2018
Q3 2017 -324% +1151% +78% 01 Jul 2017 30 Sep 2017
Q2 2017 -516% +575% +53% 01 Apr 2017 30 Jun 2017
Q1 2017 -2323% -1501% -183% 01 Jan 2017 31 Mar 2017
Q4 2016 -1343% -871% -184% 01 Oct 2016 31 Dec 2016
Q3 2016 -1475% -1094% -286% 01 Jul 2016 30 Sep 2016
Q2 2016 -1090% -810% -289% 01 Apr 2016 30 Jun 2016
Q1 2016 -822% 01 Jan 2016 31 Mar 2016
Q4 2015 -472% 01 Oct 2015 31 Dec 2015
Q3 2015 -382% 01 Jul 2015 30 Sep 2015
Q2 2015 -280% 01 Apr 2015 30 Jun 2015

Hepion Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -548% -323% -144% 01 Jan 2024 31 Dec 2024
2023 -225% -161% -251% 01 Jan 2023 31 Dec 2023
2022 -64% -33% -108% 01 Jan 2022 31 Dec 2022
2021 -31% +60% +66% 01 Jan 2021 31 Dec 2021
2020 -91% -35% -61% 01 Jan 2020 31 Dec 2020
2019 -57% +379% +87% 01 Jan 2019 31 Dec 2019
2018 -436% +80% +16% 01 Jan 2018 31 Dec 2018
2017 -516% +575% +53% 01 Jul 2016 30 Jun 2017
2016 -1090% -810% -289% 01 Jul 2015 30 Jun 2016
2015 -280% -471% -247% 01 Jul 2014 30 Jun 2015
2014 191% 01 Jul 2013 30 Jun 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.